LITTLE FALLS, N.J., Nov. 4, 2014 – CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired International Medical Service S.r.l, or IMS, for a purchase price of €19.6 million in cash consideration. Located in Pomezia, Italy, IMS is a leading manufacturer of high-level disinfectant chemistries used in automated endoscope reprocessors (AERs) as well as other infection prevention and control chemistries used in healthcare and dental markets. In addition, IMS is a manufacturer of high-quality AERs and holds leading share in the Italian AER market. IMS has an employee base of approximately 60 individuals including a complete sales and service team for the Italian market as well as a robust engineering group.
“The addition of IMS to our Medivators Endoscopy segment compliments this business with the most competitive global AER portfolio and adds key global R&D and manufacturing capabilities to our organization,” said Jorgen Hansen, President of Medivators and COO of Cantel Medical. “We look forward to manufacturing both IMS’ line of chemistries as well as Medivators’ range of infection prevention chemistries at the IMS facility for sale throughout the European continent.”